Pharmaceutical company Organon & Co. (NYSE: OGN) has reported higher revenues and adjusted earnings for the fourth quarter of 2023.
- Total revenue increased 8% annually to $1.60 billion in Q4, both on a reported basis and excluding the impact of foreign currency
- Women’s Health revenue increased 7% year-over-year, driven primarily by strong growth in Organon’s fertility products
- Biosimilar revenue jumped 49% from last year as reported, and 48% on an FX-adjusted basis in Q4
- Established Brands revenue rose 3%, despite the impacts of Volume-Based Procurement initiatives and a challenging operating environment in China
- Q4 net income more than doubled to $546 million or $2.13 per share in the three months ended December 2023
- On an adjusted basis, earnings moved up to $0.88 per share in Q4 from $0.81 per share last year
- At $449 million, fourth-quarter adjusted EBITDA was up 18% from the year-ago quarter.
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Home Depot (HD) Q1 2024 Earnings: Key financials and quarterly highlights
The Home Depot (NYSE: HD) reported first quarter 2024 earnings results today. Sales decreased 2.3% year-over-year to $36.4 billion. Comparable sales decreased 2.8%. Net earnings were $3.6 billion, or $3.63 per share, compared
Applied Materials (AMAT) is set to report Q2 results. Here’s what to expect
Applied Materials, Inc. (NASDAQ: AMAT), a leading supplier of semiconductor fabrication equipment, has successfully navigated through market challenges, aided by its diversified customer base and continued innovation. The tech firm
What to expect when Lowe’s Companies (LOW) reports Q1 2024 earnings results
Shares of Lowe's Companies, Inc. (NYSE: LOW) were down over 1% on Monday. The stock has gained over 4% year-to-date. The home improvement retailer is scheduled to report its first
